Neurophenotyping is the study of how specified genes, subjected to environmental influences and stressors, modify the brain, behavior and cognitive function. The objective is to identify potential risk factors that contribute to the vulnerability for mental illness and the development of abnormal behavior, as well as to pinpoint new interventions that might correct these deficits.
Founded in 2006 with the support of the Quebec Transgenic Research Network (QTRN), the Neurophenotyping Centre consists of a team of internationally recognized investigators. It provides, to the scientific community of Quebec and Canada, the expertise required to meet all of the challenges related to behavioral analysis. Specifically, the Center offers:
- Consultation on the behavioral tests most appropriate for testing the hypothesis under investigation Development of experimental design and animal testing
- Statistical analysis and data interpretation
- Preparation of publication-ready reports
The platform has expanded, and since October 2008, occupies the new Neurophenotyping Centre. The new building houses more animals (rats and mice) in more naturalistic environments. Top-of-the-line facilities also allow researchers to study in optimal conditions.
Contact us
Neurophenotyping Centre
Douglas Institute
Perry Pavilion, Office E-2127
6875, LaSalle bvld.
Montréal (Québec) H4H 1R3
For a quotation or request for service, please contact:
Eve-Marie Charbonneau, coordinator
514-761-6131, ext. 3342
behavioral_dot_phenotyping_At_douglas_dot_mcgill_dot_ca
Joseph Rochford, PhD, director of the Behaviour Platform
514-761-6131 ext. 3433
joseph_dot_rochford_At_douglas_dot_mcgill_dot_ca
All tests are made in accordance with the guidelines of the Canadian Council of Protection of Animals (CCPA).
View more pictures from the Unveilling of the Neurophenotyping Centre on Flickr.
